Patent application number | Description | Published |
20130283350 | ACCESS AUTHORIZATION - Methods, systems, and computer-readable media with executable instructions stored thereon for managing access authorization to hardware and data resources. A method includes defining a property of a hardware and/or data resource. This example method further includes defining a role such that each defined role can be applied to different users without modification, defining a security domain for the property of the resource in the context of a user-role assignment and assigning a role to a user in a context of the defined security domain. | 10-24-2013 |
20140351414 | Systems And Methods For Providing Prediction-Based Dynamic Monitoring - Dynamic monitoring of an element in a network is provided by predicting whether a resource threshold crossing, such as load-based level, is likely to be exceeded within a certain time period. If the level is likely to be exceeded shortly, the monitoring rate of the element for a given time period may be increased. Conversely, if the level is unlikely to be exceeded in the near term, the monitoring rate may be decreased. | 11-27-2014 |
20150032894 | PROFILE-BASED SLA GUARANTEES UNDER WORKLOAD MIGRATION IN A DISTRIBUTED CLOUD - Various exemplary embodiments relate to a method and related network node including one or more of the following: receiving performance metrics from at least one device within the cloud network; analyzing the performance metrics to generate at least one application requirement, wherein the at least one application requirement indicates a recent performance associated with a resource provisioned for a customer, wherein the resource is supported by a first device within the cloud network; identifying a second device within the cloud network to support the resource based on the at least one application requirement; and migrating the resource from the first device to the second device. | 01-29-2015 |
Patent application number | Description | Published |
20100287631 | WNT PATHWAY MUTATIONS IN CANCER STEM CELLS - Cancer specific splicing events in the Wnt/β-catenin signaling pathway are associated with progression of myelogenous leukemia. Misspliced genes of interest include GSK3β. In some embodiments of the invention, polynucleotides are provided that correspond to misspliced GSK3β transcripts associated with cancer. Such transcripts are characterized by a deletion of exon (8), and particularly in exon (8) and (9). Detection of such transcripts in cells is indicative of the presence of leukemia, and particularly of the presence of leukemia stem cells. In other embodiments, polypeptides are provided that are encoded by misspliced GSK3β transcripts associated with cancer. Such polypeptides are useful as diagnostic markers for cancer, and as a target for screening of therapeutic agents. Animal models comprising a human LSC having a misspliced GSK3b transcript provide a useful model for leukemia, for drug/gene screening in the prevention and treatment of leukemia in humans, etc. | 11-11-2010 |
20110059448 | COMPOSITIONS AND METHODS FOR DETERMINING CANCER STEM CELL SELF-RENEWAL POTENTIAL - In alternative embodiments, the invention provides compositions and methods for determining the self-renewal potential of a cancer stem cell (CSC) through analysis of the cross-talk between cell self-renewal pathways leading to deregulation and enhanced self-renewal of the CSC, or for predicting the drugability (susceptibility to a drug) of a CSC, and/or for predicting the progression of a cancer that corresponds to the CSC, the method comprising detecting and quantifying in CSCs one or more B-cell lymphoma-2 (Bcl-2) family protein isoform(s) or transcripts (mRNAs, messages) encoding one or more Bcl-2 family protein(s) or protein isoform(s) thereof. In alternative embodiments, the invention provides compositions and methods to determine and measure the levels of Wnt, glycogen synthase kinase-3 beta (GSK-3 beta), glycogen synthase kinase-3 alpha (GSK-3 alpha), and/or Sonic Hedgehog Homolog (SHH or Shh) family proteins and alternatively spliced transcripts (mRNAs), and Wnt, GSK3beta, GSK3alpha and/or Shh family protein and alternatively spliced transcript ratios in cancer cells, e.g., stem cells, e.g., CSCs, for diagnostic, drug discovery and prognostic purposes. | 03-10-2011 |
20110243853 | MODELS OF ERYTHROPOIESIS - Non human animal models are provided for diseases involving erythroid function, particularly myeloproliferative disease. The models are useful for testing and screening of biologically active agents that affect erythropoiesis, and erythroid function. In the animal models of the invention, a hematopoietic stem or progenitor cell (HSC) population that has been genetically altered by the introduction of a mutant JAK2 coding sequence is transplanted into an immunocompromised, xenogeneic, non-human recipient. The recipient animal is engrafted with the cell population at a high frequency, and develops a myeloproliferative disorder characterized by polycythemia. | 10-06-2011 |
Patent application number | Description | Published |
20110045049 | IMMUNOMODULATING COMPOSITIONS AND METHODS OF USE - This invention is directed to β-1-6-glucans, compositions and devices comprising the same, and methods of use thereof in modulating immune responses. The β-1-6-glucans of certain embodiments of the invention are enriched for O-acetylated groups and/or conjugated to a solid support or linked to a targeting moiety. | 02-24-2011 |
20110177532 | IMMUNOMODULATING COMPOSITIONS AND METHODS OF USE THEREOF - The invention is directed to β1-6 glucans, compositions, diagnostic kits, and devices comprising the same, and methods of use thereof in modulating immune response and treating, delaying progression of, reducing the incidence or severity of cancer, infection, inflammation, and autoimmune diseases. The β1-6 glucans of certain embodiments of the invention are enriched for O-acetylated groups and/or conjugated to a solid support or linked to a targeting moiety. The β1-6 glucans of certain embodiments of the invention recruit immunoglobulin G antibodies to mediate complement and neutrophil killing. The conjugated β1-6 glucans of certain embodiments of the invention are targeted to cells to stimulate the immune response at the target location by activating complement-mediated lysis and recruitment of neutrophils. | 07-21-2011 |
20140030277 | IMMUNOMODULATING COMPOSITIONS AND METHODS OF USE THEREOF - This invention is directed to β-1-6-glucans, compositions and devices comprising the same, and methods of use thereof in modulating immune responses. The β-1-6-glucans of certain embodiments of the invention are enriched for O-acetylated groups and/or conjugated to a solid support or linked to a targeting moiety. | 01-30-2014 |
20140308238 | IMMUNOMODULATING COMPOSITIONS AND METHODS OF USE THEREOF - The invention is directed to β1-6 glucans, compositions, diagnostic kits, and devices comprising the same, and methods of use thereof in modulating immune response and treating, delaying progression of, reducing the incidence or severity of cancer, infection, inflammation, and autoimmune diseases. The β1-6 glucans of certain embodiments of the invention are enriched for O-acetylated groups and/or conjugated to a solid support or linked to a targeting moiety. The β1-6 glucans of certain embodiments of the invention recruit immunoglobulin G antibodies to mediate complement and neutrophil killing. The conjugated β1-6 glucans of certain embodiments of the invention are targeted to cells to stimulate the immune response at the target location by activating complement-mediated lysis and recruitment of neutrophils. | 10-16-2014 |
Patent application number | Description | Published |
20080225063 | Photo-curable ink-jet ink compositions, systems, and methods - The present invention is drawn to photo-curable ink-jet ink compositions, systems, and methods. One exemplary ink-jet ink composition includes a liquid vehicle, a milled pigment which has been milled in a milling solvent having minimal to no gas solvency for the milled pigment, and a photo initiator. In this embodiment, the composition can be ink-jettable at frequencies of at least 29 KHz without requiring degassing during printing. | 09-18-2008 |
20080225099 | Photo-curable Ink-jet Ink Compositions, Systems, And Methods - The present invention is drawn to photo-curable ink-jet ink compositions, systems, and methods. One exemplary ink-jet ink composition includes a liquid vehicle, a milled pigment which has been milled in a milling solvent having minimal to no gas solvency for the milled pigment, and a photo initiator. In this embodiment, the composition can be ink-jettable at frequencies of at least 29 KHz without requiring degassing during printing. | 09-18-2008 |